Company profile for Apriligen

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Apriligen is a clinical-stage biotechnology company focused on developing gene therapies for rare pediatric diseases. Founded in 2020, it leverages a proprietary lentiviral vector platform to deliver curative, autologous treatments targeting monogenic disorders. Its lead candidate, APR-2020, aims to treat Diamond-Blackfan Anemia by restoring normal gene function. The company is committed to advancing scalable, life-changing th...
Apriligen is a clinical-stage biotechnology company focused on developing gene therapies for rare pediatric diseases. Founded in 2020, it leverages a proprietary lentiviral vector platform to deliver curative, autologous treatments targeting monogenic disorders. Its lead candidate, APR-2020, aims to treat Diamond-Blackfan Anemia by restoring normal gene function. The company is committed to advancing scalable, life-changing therapies for underserved patient populations.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Greenwich, Connecticut
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty